The canine model of human cognitive aging and dementia: Pharmacological validity of the model for assessment of human cognitive-enhancing drugs

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 3, 2005, Pages 489-498

  Studzinski, Christa M ^a   Araujo, Joseph A ^a   Milgram, Norton W ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acetylcholinesterase inhibitor; Aging; Alzheimer's disease; Ampakine; Cognition; Dementia; Dog; Pharmacological validity; Selegiline

Indexed keywords

6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; ADRAFINIL; ALZHEIMER DISEASE VACCINE; AMPA RECEPTOR AGONIST; AMPAKINE; CHOLINESTERASE INHIBITOR; CP 118954; CP 531708; MODAFINIL; PHENSERINE; SELEGILINE; UNCLASSIFIED DRUG;

ACCURACY; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COST CONTROL; DISEASE COURSE; DOG; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG UTILIZATION; HUMAN; LEARNING DISORDER; MEMORY DISORDER; MENINGOENCEPHALITIS; NEUROPATHOLOGY; NONHUMAN; OBSERVATION; PARKINSON DISEASE; PREDICTION; PSYCHOLOGIC ASSESSMENT; SIDE EFFECT; STEREOTYPY; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 15744400473     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.12.014     Document Type: Review

References (72)

1. B. Adams, A. Chan, H. Callahan, and N.W. Milgram The canine as a model of human cognitive aging: recent developments Prog. Neuro-Psychopharmacol. Biol. Psychiatry 24 2000 675 692
2. B. Adams, A. Chan, H. Callahan, C. Siwak, D. Tapp, C. Ikeda-Douglas, P. Atkinson, E. Head, C.W. Cotman, and N.W. Milgram Use of a delayed non-matching to position task to model age-dependent cognitive decline in the dog Behav. Brain Res. 108 2000 47 56
3. A. Adelman Selegiline and vitamin E in Alzheimer's disease J. Fam. Pract. 45 1997 98 100
4. I. Alafuzoff, S. Helisalmi, E.H. Heinonen, K. Reinikainen, M. Hallikainen, H. Soininen, and K. Koivisto Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's disease Eur. J. Clin. Pharmacol. 55 2000 815 819
5. J.A. Araujo, A.D.F. Chan, L.L. Winka, P.A. Seymour, and N.W. Milgram Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination Psychopharmacology 175 2004 92 98
6. B.Y. Azizeh, E. Head, M.A. Ibrahim, R. Torp, A.J. Tenner, R.C. Kim, I.T. Lott, and C.W. Cotman Molecular dating of senile plaques in the brains of individuals with Down syndrome and in aged dogs Exp. Neurol. 163 2000 111 122
7. A.J. Barber, P.H. Yu, and A.A. Boulton Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice Life Sci. 53 1993 739 747
8. R.T. Bartus Physostigmine and recent memory: effects in young and aged nonhuman primates Science 206 4422 1979 1087 1089
9. R.T. Bartus On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis Exp. Neurol. 163 2000 495 529
10. R.T. Bartus, and R.L. Dean Tetrahydroaminoacridine, 3,4 diaminopyridine and physostigmine: direct comparison of effects on memory in aged primates Neurobiol. Aging 9 4 1988 351 356
11. R.T. Bartus, R.L.I. Dean, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
12. D. Beracochea, A. Celerier, N. Borde, M. Valleau, M. Peres, and C. Pierard Improvement of learning processes following chronic systemic administration of modafinil in mice Pharmacol. Biochem. Behav. 73 3 2002 723 728
13. Birks, J., Flicker L., 2003. Selegiline for Alzheimer's disease. [update of Cochrane Database Syst Rev. 2000; (2): CD000442; PMID: 10796544]. [Review] [59refs] Cochrane Database of Systematic Reviews. (1): CD000442.
14. R. Brandeis, M. Sapir, Y. Kapon, G. Borelli, S. Cadel, and B. Valsecchi Improvement of cognitive function by MAO-B inhibitor l-deprenyl in aged rats Pharmacol. Biochem. Behav. 39 1991 297 304
15. H. Callahan, C. Ikeda-Douglas, E. Head, C.W. Cotman, and N.W. Milgram Development of a protocol for studying object recognition memory in the dog Prog. Neuro-Psychopharmacol. Biol. Psychiatry 24 2000 693 707
16. S. Campbell, A. Trettien, and B. Kozan A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting Vet. Ther. 2 1 2001 24 39
17. A.D. Chan, P.M. Nippak, H. Murphey, C.J. Ikeda-Douglas, B. Muggenburg, E. Head, C.W. Cotman, and N.W. Milgram Visuospatial impairments in aged canines (Canis familiaris): the role of cognitive-behavioral flexibility Behav. Neurosci. 116 3 2002 443 454
18. C. Courtney, D. Farrell, R. Gray, R. Hills, L. Lynch, E. Sellwood, S. Edwards, W. Hardyman, J. Raftery, P. Crome, C. Lendon, H. Shaw, and P. Bentham Long term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial Lancet 363 2004 2105 2115
19. B.J. Cummings, E. Head, A.J. Afagh, N.W. Milgram, and C.W. Cotman Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine Neurobiol. Learn. Mem. 66 1996 11 23
20. B.J. Cummings, E. Head, W. Ruehl, N.W. Milgram, and C.W. Cotman The canine as an animal model of human aging and dementia Neurobiol. Aging 17 1996 259 268
21. B.J. Cummings, T. Satou, E. Head, N.W. Milgram, G.M. Cole, M.J. Savage, M.B. Podlisny, D.J. Selkoe, R. Siman, B.D. Greenberg, and C.W. Cotman Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs Neurobiol. Aging 17 1996 653 659
22. D.A. Drachman, and J. Leavitt Human memory and the cholinergic system. A relationship to aging? Arch. Neurol. 30 1974 113 121
23. F. Drago, G. Continella, F. Spadaro, S. Cavaliere, and U. Scapagnini Behavioral effects of deprenyl in aged rats Funct. Neurology 2 1986 165 174
24. C. Flicker, R.T. Bartus, T.H. Crook, and S.H. Ferris Effects of aging and dementia upon recent visuospatial memory Neurobiol. Aging 5 1984 275 283
25. C. Flicker, S.H. Ferris, and B. Reisberg Mild cognitive impairment in the elderly: predictors of dementia Neurology 41 1991 1006 1009
26. M.I. Fonseca, E. Head, P. Velazquez, C.W. Cotman, and A.J. Tenner The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age Exp. Neurol. 157 1999 277 288
27. M. Freedman, and M. Oscar-Berman Spatial and visual learning deficits in Alzheimer's and Parkinson's disease Brain Cogn. 11 1989 114 126
28. D.L. Gelowitz, J.S. Richardson, T.B. Wishart, P.H. Yu, and C. Lai Chronic l-deprenyl or l-amphetamine: equal cognitive enhancement, unequal MAO inhibition Pharmacol. Biochem. Behav. 47 1994 41 45
29. R.E. Hampson, G. Rogers, G. Lynch, and S.A. Deadwyler Facilitative effects of the ampakine CX-516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance J. Neurosci. 18 7 1998 2740 2747
30. R.E. Hampson, G. Rogers, G. Lynch, and S.A. Deadwyler Facilitative effects of the ampakine CX-516 on short-term memory in rats: correlations with hippocampal neuronal activity J. Neurosci. 18 7 1998 2748 2763
31. E. Head Brain aging in the dog: parallels with human brain aging and Alzheimer's disease Vet. Ther. 2 2001 247 260
32. E. Head, and N.W. Milgram Changes in spontaneous behavior in the dog following oral administration of l-deprenyl Pharmacol. Biochem. Behav. 43 1992 749 757
33. E. Head, and R. Torp Insights into Abeta and presenilin from a canine model of human brain aging Neurobiol. Dis. 9 2002 1 10
34. E. Head, R. Mehta, J. Hartley, M. Kameka, B.J. Cummings, C.W. Cotman, W.W. Ruehl, and N.W. Milgram Spatial learning and memory as a function of age in the dog Behav. Neurosci. 109 1995 851 858
35. E. Head, J. Hartley, A.M. Kameka, R. Mehta, G.O. Ivy, W.W. Ruehl, and N.W. Milgram The effects of l-deprenyl on spatial short-term memory in young and aged dogs Prog. Neuro-Psychopharmacol. Biol. Psychiatry 20 3 1996 515 530
36. E. Head, H. Callahan, B.A. Muggenburg, C.W. Cotman, and N.W. Milgram Visual-discrimination learning ability and beta-amyloid accumulation in the dog Neurobiol. Aging 19 1998 415 425
37. E. Head, R. McCleary, F.F. Hahn, N.W. Milgram, and C.W. Cotman Region-specific age at onset of beta-amyloid in dogs Neurobiol. Aging 21 2000 89 96
38. E. Head, J. Liu, T.M. Hagen, B.A. Muggenburg, N.W. Milgram, B.N. Ames, and C.W. Cotman Oxidative damage increases with age in a canine model of human brain aging J. Neurochem. 82 2002 375 381
39. H. Ikari, E.L. Spangler, N.H. Greig, X.F. Pei, A. Brossi, D. Speer, N. Patel, and D.K. Ingram Maze learning in aged rats is enhanced by phenserine, a novel anticholinesterase NeuroReport 6 1995 481 484
40. S.A. Johnson, and V.F. Simmon Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report J. Mol. Neurosci. 1999 197 200
41. E.M. Johnstone, M.O. Chaney, F.H. Norris, R. Pascual, and S.P. Little Conservation of the sequence of Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis Mol. Brain Res. 10 1991 299 305
42. J. Knoll The pharmacology of selegiline ((-)deprenyl). New aspects Acta Neurol. Scand. 126 1989 83 91
43. Lundbeck Institute, 2003. Icopezil maleate. http://www.psychotropics.dk/ usr_view_molecule.asp?ID=2265&backurl= Codeindex%2Fview%5FCodes%2Easp%3FStartchar%3DC&backurlname= Code+numbers&historyline=&Catalogtype=A.
44. N.W. Milgram Cognitive experience and its effect on age-dependent cognitive decline in beagle dogs Neurochem. Res. 28 2003 1677 1682
45. N.W. Milgram, E. Head, E. Weiner, and E. Thomas Cognitive functions and aging in the dog: acquisition of nonspatial visual tasks Behav. Neurosci. 108 1994 57 68
46. N.W. Milgram, G.O. Ivy, E. Head, M.P. Murphy, P.H. Wu, W.W. Ruehl, P.H. Yu, D.A. Durden, B.A. Davis, and A.A. Boulton Effects of chronic oral administration of l-deprenyl in the dog Pharmacol. Biochem. Behav. 51 1995 421 428
47. N.W. Milgram, B. Adams, H. Callahan, E. Head, B. Mackay, C. Thirlwell, and C.W. Cotman Landmark discrimination learning in the dog Learn. Memory 6 1999 54 61
48. N.W. Milgram, C.T. Siwak, P. Gruet, P. Atkinson, F. Woehrle, and H. Callahan Oral administration of adrafinil improves discrimination learning in aged beagle dogs Pharmacol. Biochem. Behav. 66 2 2000 301 305
49. N.W. Milgram, E. Head, B. Muggenburg, D. Holowachuk, H. Murphey, J. Estrada, C.J. Ikeda-Douglas, S.C. Zicker, and C.W. Cotman Landmark discrimination learning in the dog: effects of age, an antioxidant fortified food, and cognitive strategy Neurosci. Biobehav. Rev. 26 2002 679 695
50. N.W. Milgram, S.C. Zicker, E. Head, B.A. Muggenburg, H. Murphey, C.J. Ikeda-Douglas, and C.W. Cotman Dietary enrichment counteracts age-associated cognitive dysfunction in canines Neurobiol. Aging 23 5 2002 737 745
51. R.G. Morris, and A.D. Baddeley Primary and working memory functioning in Alzheimer-type dementia J. Clin. Exp. Neuropsychol. 10 1988 279 296
52. E. Nowakowska, K. Kus, A. Chodera, and J. Rybakowski Investigating potential anxiolytic, antidepressant and memory enhancing activity of deprenyl J. Physiol. Pharmacol. 52 2001 t-73
53. Osborne, R., 2004. Cortex's ampakine CX516 fizzles, but more potent ones in pipeline. Bioworld Online. http://www.bioworld.com/servlet/com.accumedia.web. Dispatcher?next=bioWorldHeadlines_article&forceid=32153.
54. N. Patel, E.L. Spangler, N.H. Greig, Q.S. Yu, D.K. Ingram, and R.C. Meyer Phenserine, a novel acetylcholinesterase inhibitor, attenuates impaired learning of rats in a 14-unit T-maze induced by blockade of the N-methyl-d-aspartate receptor NeuroReport 9 1998 171 176
55. G. Riedel, B. Platt, and J. Micheau Glutamate receptor function in learning and memory Behav. Brain Res. 140 2003 1 47
56. S.R. Robinson, G.M. Bishop, H.-G. Lee, and G. Münch Lessons from AN 1792 Alzheimer vaccine: lest we forget Neurobiol. Aging 25 2004 609 615
57. W.W. Ruehl, and B.L. Hart Canine cognitive dysfunction Psychopharmacology of animal behavior disorders 1998 283 304
58. W.W. Ruehl, D.S. Bruyette, A. DePaoli, C.W. Cotman, E. Head, N.W. Milgram, and B.J. Cummings Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to l-deprenyl therapy Prog. Brain Res. 106 1995 217 225
59. T. Satou, B.J. Cummings, E. Head, K.A. Nielson, F.F. Hahn, N.W. Milgram, P. Velazquez, D.H. Cribbs, A.J. Tenner, and C.W. Cotman The progression of beta-amyloid deposition in the frontal cortex of the aged canine Brain Res. 774 1997 35 43
60. D.J. Selkoe, D.S. Bell, M.B. Podlisny, D.L. Price, and L.C. Cork Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease Science 235 1987 873 877
61. C.T. Siwak, H. Callahan, and N.W. Milgram Adrafinil: effects on behavior and cognition in aged canines Prog. Neuro-Psychopharmacol. Biol. Psychiatry 24 2000 709 726
62. C.T. Siwak, P. Gruet, F. Woehrle, M. Schneider, B.A. Muggenberg, H.L. Murphey, H. Callahan, and N.W. Milgram Behavioral activating effects of adrafinil in aged canines Pharmacol. Biochem. Behav. 66 2000 293 300
63. C.T. Siwak, P.D. Tapp, and N.W. Milgram Adrafinil disrupts performance on a delayed nonmatching-to-position task in aged beagle dogs Pharmacol. Biochem. Behav. 76 1 2003 161 168
64. M.Y. Su, E. Head, W.M. Brooks, Z. Wang, B.A. Muggenburg, G.E. Adam, R. Sutherland, C.W. Cotman, and O. Nalcioglu Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging Neurobiol. Aging 19 1998 479 485
65. P.D. Tapp, C.T. Siwak, J. Estrada, E. Head, B.A. Muggenburg, C.W. Cotman, and N.W. Milgram Size and reversal learning in the beagle dog as a measure of executive function and inhibitory control in aging Learn. Memory 10 2003 64 73
66. P.D. Tapp, C.T. Siwak, J. Estrada, D. Holowachuk, and N.W. Milgram Effects of age on measures of complex working memory span in the beagle dog (Canis familiaris) using two versions of a spatial list learning paradigm Learn. Memory 10 2003 148 160
67. R. Torp, E. Head, and C.W. Cotman Ultrastructural analyses of beta-amyloid in the aged dog brain: neuronal beta-amyloid is localized to the plasma membrane Prog. Neuro-Psychopharmacol. Biol. Psychiatry 24 2000 801 810
68. R. Torp, E. Head, N.W. Milgram, F. Hahn, O.P. Ottersen, and C.W. Cotman Ultrastructural evidence of fibrillar beta-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains Neuroscience 96 2000 495 506
69. Tufts Center for the Study of Drug Development, 2004. Outlook 2004. http://csdd.tufts.edu/InfoServices/OutlookPDFs/Outlook2004.pdf.
70. G.K. Wilcock, J. Birks, A. Whitehead, and S.J. Evans The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials Int. J. Geriatr. Psychiatry 17 2002 175 183
71. K. Yamada, and T. Nabeshima Changes in NMDA receptor/nitric oxide signaling pathway in the brain with aging Microsc. Res. Tech. 43 1998 68 74
72. L. Yavich, J. Sirvio, E. Heinonen, and S.P. Riekkinen The interaction of l-deprenyl and scopolamine on spatial learning/memory in rats J. Neural Transm. 6 1993 189 197